Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Li, Y. [1 ]
Chen, Z. [2 ]
Wu, L. [1 ]
Tao, W. [1 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Hubei, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Tumor Mutation Score; Tumor Mutation Burden; PD-L1;
D O I：
10.1016/j.jtho.2019.08.1545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-40
引用
收藏
页码：S724 / S724
页数：1
相关论文
共 50 条
  • [1] Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer
    Li, Yuan
    Chen, Zuhua
    Tao, Weiping
    Sun, Nan
    He, Jie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2367 - 2378
  • [2] Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer
    Yuan Li
    Zuhua Chen
    Weiping Tao
    Nan Sun
    Jie He
    Cancer Immunology, Immunotherapy, 2021, 70 : 2367 - 2378
  • [3] Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Sharpnack, Michael F.
    Cho, Ju Hwan
    Johnson, Travis S.
    Otterson, Gregory A.
    Shields, Peter G.
    Huang, Kun
    Carbone, David P.
    He, Kai
    LUNG CANCER, 2020, 146 : 36 - 41
  • [4] Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer
    Cai, Liangliang
    Bai, Hua
    Duan, Jianchun
    Wang, Zhijie
    Gao, Shugeng
    Wang, Di
    Wang, Shuhang
    Jiang, Jun
    Han, Jiefei
    Tian, Yanhua
    Zhang, Xue
    Ye, Hao
    Li, Minghui
    Huang, Bingding
    He, Jie
    Wang, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] Genetic and Epigenetic Alterations are Associated with Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Cai, L.
    Bai, H.
    Wang, Z.
    Wang, S.
    Duan, J.
    Gao, S.
    He, J.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S377 - S377
  • [6] Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy
    Nie, Wei
    Xu, Mi-Die
    Gan, Lu
    Zhang, Yi
    Qian, Jie
    Gu, Kai
    Zhang, Xue-Yan
    Wang, Hui-Min
    Yan, Bo
    Gu, Ping
    Zhang, Bo
    Wang, Shu-Yuan
    Hu, Fang
    Li, Chang-Hui
    Zhong, Hua
    Han, Bao-Hui
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (06) : 189 - 195
  • [7] Smoking Status Is Not a Replacement Biomarker for Tumor Mutation Burden in Non-Small Lung Cancer
    Sharpnack, M.
    Cho, J. H.
    Johnson, T.
    Otterson, G.
    Shields, P.
    Huang, K.
    Carbone, D.
    He, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S444 - S445
  • [8] Prediction performance of twelve tumor mutation burden panels in melanoma and non-small cell lung cancer
    Xu, Dechen
    Li, Jie
    Wang, Dong
    Zhou, Li
    Jin, Jiahuan
    Wang, Yadong
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 169
  • [9] Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients
    Song, Peng
    Yang, Dongliang
    Wang, Hanping
    Cui, Xiaoxia
    Si, Xiaoyan
    Zhang, Xiaotong
    Zhang, Li
    THORACIC CANCER, 2020, 11 (06) : 1647 - 1654
  • [10] Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report
    Owada-Ozaki, Yuki
    Muto, Satoshi
    Takagi, Hironori
    Inoue, Takuya
    Watanabe, Yuzuru
    Fukuhara, Mitsuro
    Yamaura, Takumi
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Ohsugi, Jun
    Hoshino, Mika
    Shio, Yutaka
    Nanamiya, Hideaki
    Imai, Jun-ichi
    Isogai, Takao
    Watanabe, Shinya
    Suzuki, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : 1217 - 1221
12345